Literature DB >> 22431779

DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?

Edward W Cowen, Raphaela Goldbach-Mansky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22431779      PMCID： PMC3464919          DOI： 10.1001/archdermatol.2011.3014

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  25 in total

1.  Identification and initial characterization of four novel members of the interleukin-1 family.

Authors:  S Kumar; P C McDonnell; R Lehr; L Tierney; M N Tzimas; D E Griswold; E A Capper; R Tal-Singer; G I Wells; M L Doyle; P R Young
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.

Authors:  Virginie Lutz; Dan Lipsker
Journal:  Arch Dermatol       Date:  2012-03

3.  Four new members expand the interleukin-1 superfamily.

Authors:  D E Smith; B R Renshaw; R R Ketchem; M Kubin; K E Garka; J E Sims
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

4.  Chronic cutaneous pustulosis due to a 175-kb deletion on chromosome 2q13: excellent response to anakinra.

Authors:  Cristina N Brau-Javier; Jose Gonzales-Chavez; Jorge R Toro
Journal:  Arch Dermatol       Date:  2012-03

5.  Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2.

Authors:  R Debets; J C Timans; B Homey; S Zurawski; T R Sana; S Lo; J Wagner; G Edwards; T Clifford; S Menon; J F Bazan; R A Kastelein
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.

Authors:  Jennifer E Towne; Kirsten E Garka; Blair R Renshaw; G Duke Virca; John E Sims
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

7.  Interleukin-1 receptor antagonist production by human keratinocytes.

Authors:  C F Bigler; D A Norris; W L Weston; W P Arend
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

8.  Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells.

Authors:  Lisa C Zaba; Judilyn Fuentes-Duculan; Narat John Eungdamrong; Maria Veronica Abello; Inna Novitskaya; Katherine C Pierson; Juana Gonzalez; James G Krueger; Michelle A Lowes
Journal:  J Invest Dermatol       Date:  2008-07-17       Impact factor: 8.551

Review 9.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

Authors:  Hal Blumberg; Huyen Dinh; Esther S Trueblood; James Pretorius; David Kugler; Ning Weng; Suzanne T Kanaly; Jennifer E Towne; Cynthia R Willis; Melanie K Kuechle; John E Sims; Jacques J Peschon
Journal:  J Exp Med       Date:  2007-10-01       Impact factor: 14.307
View more
  13 in total

Review 1.  Moving towards a systems-based classification of innate immune-mediated diseases.

Authors:  Sinisa Savic; Emily A Caseley; Michael F McDermott
Journal:  Nat Rev Rheumatol       Date:  2020-02-27       Impact factor: 20.543

2.  Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist.

Authors:  Megha Garg; Adriana A de Jesus; Dawn Chapelle; Paul Dancey; Ronit Herzog; Rafael Rivas-Chacon; Theresa L Wampler Muskardin; Ann Reed; James C Reynolds; Raphaela Goldbach-Mansky; Gina A Montealegre Sanchez
Journal:  JCI Insight       Date:  2017-08-17

Review 3.  Autoinflammatory syndromes.

Authors:  John J Cush
Journal:  Dermatol Clin       Date:  2013-07       Impact factor: 3.478

Review 4.  Regulating against the dysregulation: new treatment options in autoinflammation.

Authors:  Tilmann Kallinich
Journal:  Semin Immunopathol       Date:  2015-06-10       Impact factor: 9.623

5.  DNAX-activating protein 10 (DAP10) membrane adaptor associates with receptor for advanced glycation end products (RAGE) and modulates the RAGE-triggered signaling pathway in human keratinocytes.

Authors:  Masakiyo Sakaguchi; Hitoshi Murata; Yumi Aoyama; Toshihiko Hibino; Endy Widya Putranto; I Made Winarsa Ruma; Yusuke Inoue; Yoshihiko Sakaguchi; Ken-Ichi Yamamoto; Rie Kinoshita; Junichiro Futami; Ken Kataoka; Keiji Iwatsuki; Nam-Ho Huh
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

Review 6.  New players driving inflammation in monogenic autoinflammatory diseases.

Authors:  Fabio Martinon; Ivona Aksentijevich
Journal:  Nat Rev Rheumatol       Date:  2014-09-23       Impact factor: 20.543

7.  Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.

Authors:  Joseph S Ainscough; Tom Macleod; Dennis McGonagle; Rosella Brakefield; Jens M Baron; Ade Alase; Miriam Wittmann; Martin Stacey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

Review 8.  Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease.

Authors:  David B Beck; Ivona Aksentijevich
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

9.  Retrospective analysis of model-based predictivity of human pharmacokinetics for anti-IL-36R monoclonal antibody MAB92 using a rat anti-mouse IL-36R monoclonal antibody and RNA expression data (FANTOM5).

Authors:  Jennifer Ahlberg; Craig Giragossian; Hua Li; Maria Myzithras; Ernie Raymond; Gary Caviness; Christine Grimaldi; Su-Ellen Brown; Rocio Perez; Danlin Yang; Rachel Kroe-Barrett; David Joseph; Chandrasena Pamulapati; Kelly Coble; Peter Ruus; Joseph R Woska; Rajkumar Ganesan; Steven Hansel; M Lamine Mbow
Journal:  MAbs       Date:  2019-06-04       Impact factor: 5.857

10.  Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies.

Authors:  Rajkumar Ganesan; Ernest L Raymond; Detlev Mennerich; Joseph R Woska; Gary Caviness; Christine Grimaldi; Jennifer Ahlberg; Rocio Perez; Simon Roberts; Danlin Yang; Kavita Jerath; Kristopher Truncali; Lee Frego; Eliud Sepulveda; Priyanka Gupta; Su-Ellen Brown; Michael D Howell; Keith A Canada; Rachel Kroe-Barrett; Jay S Fine; Sanjaya Singh; M Lamine Mbow
Journal:  MAbs       Date:  2017-07-20       Impact factor: 5.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.